| S8452 |
BAY-876
|
BAY-876 is a potent and selective GLUT1 inhibitor (IC50=0.002 μM) with a selectivity factor of >100 against GLUT2, GLUT3, and GLUT4.
|
-
BMC Cancer, 2025, 25(1):716
-
Am J Pathol, 2024, S0002-9440(24)00116-0
-
Cancer Cell Int, 2024, 24(1):19
|
|
| S7927 |
WZB117
|
WZB117 is an inhibitor of Glucose Transporter 1 (GLUT1). It inhibited cell proliferation in lung cancer A549 cells and breast cancer MCF7 cells with an IC50 of approximately 10 μM.
|
-
Nat Commun, 2025, 16(1):4929
-
Nat Commun, 2024, 15(1):4363
-
Am J Pathol, 2024, S0002-9440(24)00116-0
|
|
| S7931 |
STF-31
|
STF-31 is a selective glucose transporter GLUT1 inhibitor.
|
-
Cancer Cell Int, 2025, 25(1):199
-
Immunity, 2022, 55(1):159-173.e9
-
J Control Release, 2022, 352:540-555
|
|
| S9636 |
DRB18
|
DRB18 is a pan-GLUT (glucose transporters) inhibitor that inhibits growth and proliferation in several different cancer types with IC50 high nM range.
|
-
Cancer Cell, 2022, 40(10):1207-1222.e10
-
Cancers (Basel), 2022, 14(13)3225
|
|
| E0805 |
KL-11743
|
KL-11743 is a potent glucose-competitive inhibitor of the class I glucose transporters with IC50s of 115, 137 and 90 nM for GLUT1, GLUT2, and GLUT3.
|
-
Sci Rep, 2024, 14(1):15340
|
|
| S5748 |
4′-Deoxyphlorizin
|
4'-Deoxyphlorizin is an inhibitor of the glucose transport system.
|
|
|
| S0235 |
Lavendustin B
|
Lavendustin B inhibits HIV-1 integrase (IN) interaction with its cognate cellular cofactor lens epithelium-derived growth factor (LEDGF/p75). This compound is an inhibitor of Tyrosine Kinase and also a competitive inhibitor of glucose transporter 1 (Glut1).
|
|
|